{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:01:41Z","timestamp":1784937701004,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jacadv.2026.102668","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:39:49Z","timestamp":1773664789000},"page":"102668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Clinical Impact of Patent Foramen Ovale in Patients With Carcinoid Heart Disease"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-9767","authenticated-orcid":false,"given":"Isabel G.","family":"Scalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar H.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0758-1086","authenticated-orcid":false,"given":"Fatmaelzahraa E.","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia C.","family":"Villa-Etchengoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5824-8485","authenticated-orcid":false,"given":"Juan M.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros Pereyra","family":"Pietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Bassam","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Crestanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartzell V.","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-9591","authenticated-orcid":false,"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Allen","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-3521","authenticated-orcid":false,"given":"Patricia A.","family":"Pellikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Arsanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102668_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacadv.2026.102668_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of neuroendocrine neoplasms in the US","volume":"8","author":"Dasari","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacadv.2026.102668_bib3","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995-2018: a retrospective, population-based study","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jacadv.2026.102668_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13264","article-title":"Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021","volume":"35","author":"Thiis-Evensen","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jacadv.2026.102668_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid Heart Disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102668_bib6","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid Heart Disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102668_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/endrev\/bnad035","article-title":"What is Carcinoid Syndrome? A critical appraisal of its proposed mediators","volume":"45","author":"Mulders","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacadv.2026.102668_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of Carcinoid Syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jacadv.2026.102668_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for Carcinoid Syndrome and Carcinoid Heart Disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jacadv.2026.102668_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"Carcinoid Heart Disease: from pathophysiology to Treatment--'Something in the way it moves'","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacadv.2026.102668_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3332\/ecancer.2016.662","article-title":"Complications from carcinoid syndrome: review of the current evidence","volume":"10","author":"Mota","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jacadv.2026.102668_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.echo.2025.05.013","article-title":"Echocardiographic evaluation of Carcinoid Heart Disease","volume":"38","author":"Ayoub","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacadv.2026.102668_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/clc.4960180212","article-title":"Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part I","volume":"18","author":"Waller","year":"1995","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacadv.2026.102668_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14503\/THIJ-17-6562","article-title":"Carcinoid Heart Disease: review of current knowledge","volume":"46","author":"Ram","year":"2019","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacadv.2026.102668_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.102668_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for Carcinoid Heart Disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102668_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for Carcinoid Heart Disease","volume":"158","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacadv.2026.102668_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2018.09.009","article-title":"Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?","volume":"140","author":"Ayme-Dietrich","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacadv.2026.102668_bib19","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1161\/hc37t1.094898","article-title":"Surgical management of left-sided carcinoid heart disease","volume":"104","author":"Connolly","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102668_bib20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jtho.2018.06.023","article-title":"Carcinoid heart disease in patients with bronchopulmonary carcinoid","volume":"13","author":"De Jesus","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jacadv.2026.102668_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for surveillance and medical management of Midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.jacadv.2026.102668_bib22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102668_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacadv.2026.102668_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13060","article-title":"Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)","volume":"34","author":"Hofland","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jacadv.2026.102668_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13323","article-title":"Patent foramen ovale in carcinoid heart disease: the potential role for and risks of percutaneous closure prior to cardiothoracic surgery","volume":"35","author":"Douglas","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jacadv.2026.102668_bib26","article-title":"Carcinoid Heart Disease with hypoxemia","volume":"29","author":"Suenaga","year":"2024","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jacadv.2026.102668_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid Heart Disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacadv.2026.102668_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001060","article-title":"Multimodality imaging in Carcinoid Heart Disease","volume":"6","author":"Agha","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.jacadv.2026.102668_bib29","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.jcmg.2020.12.030","article-title":"Cardiac imaging in Carcinoid Heart Disease","volume":"14","author":"Baron","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.102668_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000506744","article-title":"Carcinoid Heart Disease: prognostic value of 5-Hydroxyindoleacetic acid levels and impact on survival: a systematic literature review","volume":"111","author":"Buchanan-Hughes","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacadv.2026.102668_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/echo.12671","article-title":"Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature","volume":"32","author":"Chowdhury","year":"2015","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacadv.2026.102668_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/STROKEAHA.123.040546","article-title":"Patent Foramen Ovale management for secondary stroke prevention: State-of-the-Art appraisal of current evidence","volume":"55","author":"Sposato","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.jacadv.2026.102668_bib33","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.3390\/cancers15225477","article-title":"The risk of venous thromboembolism in neuroendocrine neoplasms","volume":"15","author":"Wojcik-Giertuga","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacadv.2026.102668_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/cancers17020212","article-title":"Venous thromboembolism in patients with neuroendocrine neoplasms: a systematic review of incidence, types, and clinical outcomes","volume":"17","author":"Massironi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacadv.2026.102668_bib35","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/cancers14102361","article-title":"Elevated serotonin and NT-proBNP levels predict and detect carcinoid heart disease in a large validation study","volume":"14","author":"Levy","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacadv.2026.102668_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/oncolo\/oyad126","article-title":"Carcinoid heart disease management: a multi-disciplinary collaboration","volume":"28","author":"Das","year":"2023","journal-title":"Oncologist"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:05:51Z","timestamp":1784934351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2772963X26000852"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102668","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Impact of Patent Foramen Ovale in Patients With Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102668"}}